Drug Information

Drug General Information
Drug ID
D0GB8I
Former ID
DNC013203
Drug Name
N1-hydroxy-2-isobutyl-N3-phenethylmalonamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528501]
Structure
Download
2D MOL

3D MOL
Formula
C15H22N2O3
Canonical SMILES
CC(C)CC(C(=O)NCCC1=CC=CC=C1)C(=O)NO
InChI
1S/C15H22N2O3/c1-11(2)10-13(15(19)17-20)14(18)16-9-8-12-6-4-3-5-7-12/h3-7,11,13,20H,8-10H2,1-2H3,(H,16,18)(H,17,19)
InChIKey
WODYKKMWHBZSIB-UHFFFAOYSA-N
PubChem Compound ID
16114635
Target and Pathway
Target(s) Aminopeptidase N Target Info Inhibitor [528501]
BioCyc Pathway Glutathione-mediated detoxification
KEGG Pathway Glutathione metabolism
Metabolic pathways
Renin-angiotensin system
Hematopoietic cell lineage
Pathway Interaction Database C-MYB transcription factor network
PathWhiz Pathway Glutathione Metabolism
Reactome Metabolism of Angiotensinogen to Angiotensins
WikiPathways Metabolism of Angiotensinogen to Angiotensins
Cardiac Progenitor Differentiation
miR-targeted genes in squamous cell - TarBase
miR-targeted genes in muscle cell - TarBase
miR-targeted genes in lymphocytes - TarBase
miR-targeted genes in leukocytes - TarBase
Glutathione metabolism
References
Ref 528501Bioorg Med Chem. 2007 Jan 1;15(1):63-76. Epub 2006 Oct 12.A library of novel hydroxamic acids targeting the metallo-protease family: design, parallel synthesis and screening.
Ref 528501Bioorg Med Chem. 2007 Jan 1;15(1):63-76. Epub 2006 Oct 12.A library of novel hydroxamic acids targeting the metallo-protease family: design, parallel synthesis and screening.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.